Volume 40, Issue 5 p. 902-907
Commentary

Consideration of the Aerosol Transmission for COVID-19 and Public Health

Elizabeth L. Anderson

Corresponding Author

Elizabeth L. Anderson

Exponent, Inc., Health Sciences, Alexandria, VA

Address Correspondence to Elizabeth L. Anderson, Exponent, Inc., Health Sciences, Alexandria, Virginia; [email protected].

Search for more papers by this author
Paul Turnham

Paul Turnham

Exponent, Inc., Health Sciences, Alexandria, VA

Search for more papers by this author
John R. Griffin

John R. Griffin

Exponent, Inc., Health Sciences, Alexandria, VA

Search for more papers by this author
Chester C. Clarke

Chester C. Clarke

Exponent, Inc., Health Sciences, Bowie, MD

Search for more papers by this author
First published: 01 May 2020
Citations: 283

Abstract

This article analyzes the available evidence to address airborne, aerosol transmission of the SARS-CoV-2. We review and present three lines of evidence: case reports of transmission for asymptomatic individuals in association with studies that show that normal breathing and talking produce predominantly small droplets of the size that are subject to aerosol transport; limited empirical data that have recorded aerosolized SARS-CoV-2 particles that remain suspended in the air for hours and are subject to transport over distances including outside of rooms and intrabuilding, and the broader literature that further supports the importance of aerosol transmission of infectious diseases. The weight of the available evidence warrants immediate attention to address the significance of aerosols and implications for public health protection.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.